Peer-reviewedCC BY-NCMedicine
Cost-effectiveness of 13-valent pneumococcal vaccine for children under 5 years of age at high altitude in China : A modeling analysis
4 affiliations
- 1Department of Immunization Program, Qinghai Center for Disease Control and Prevention, Xining, China
- 2Department of Epidemiology and Biostatistics, School of Public Health, Fudan University, Shanghai, China
- 3Department of Respiration, Qinghai Province Women and Children’s Hospital, Xining, China
- 4Department of Public Health, Faculty of Medicine, Qinghai University, Xining, China.
Related
- Effectiveness of 20-valent pneumococcal conjugate vaccine against pneumococcal pneumonia hospitalizations among U.S. adults: Test-Negative Design
- The Health and Economic Impact of the Adult-specific 21-valent (aPCV21) Pneumococcal Conjugate Vaccine vs PCV20 on Invasive Pneumococcal Disease Among Adults Aged 65 years in the United Kingdom: A Modeling Study
- Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Reducing Mortality Among Older Adults: A Real-World Retrospective Cohort Study in Guangzhou, China.
- Association between anaemia, micronutrient status, and pneumococcal vaccine responses in young Kenyan children
- Effectiveness of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Children Aged 6 Months–6 Years During a Statewide Pertussis Outbreak — Alaska, May–November 2024
BibTeX
@article{guo2026costeffectiveness,
title = {{Cost-effectiveness of 13-valent pneumococcal vaccine for children under 5 years of age at high altitude in China : A modeling analysis}},
author = {Zizhe Guo and Hui Zhou and Chonggang Huang and Haiyan Xiong and Ruiyao Ding and Jin Xu and Xingxing Du and Xiaoqing Liu and Guiyan Ma and Xiaolin Li and Hailian Yuan and Guang Hu and Kezhong A},
journal = {Medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13706186},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Cost-effectiveness of 13-valent pneumococcal vaccine for children under 5 years of age at high altitude in China : A modeling analysis
AU - Zizhe Guo
AU - Hui Zhou
AU - Chonggang Huang
AU - Haiyan Xiong
AU - Ruiyao Ding
AU - Jin Xu
AU - Xingxing Du
AU - Xiaoqing Liu
AU - Guiyan Ma
AU - Xiaolin Li
AU - Hailian Yuan
AU - Guang Hu
AU - Kezhong A
PY - 2026
DA - 2026/10/23
JO - Medicine
UR - https://europepmc.org/article/PMC/PMC13706186
SN - 0304-5412
SN - 1536-5964
ER -